March 7, 2024

Risk assessment and analysis of pyrrolizidine alkaloids

Background:  On 1st March 2023, the Federal Institute for Medicinal Products and Medical Devices (BfArM) released its updated statement on testing pyrrolizidine alkaloid levels in order […]
Do you like it?
Read more
March 1, 2024

Analytical development of procedures for active pharmaceutical ingredients and medicinal products

Background:  The final version of ICH Q14 “Guideline on analytical procedure development” was published at the end of December 2023. It describes science and risk-based approaches […]
Do you like it?
Read more
January 22, 2024

Melatonin in food supplements

Background:  Melatonin is a hormone that is produced in the pineal gland of the brain and plays a key role in regulating the sleep-wake cycle. There […]
Do you like it?
Read more
October 22, 2023

Alternaria toxins in foodstuffs

Background:  Moulds of the genus Alternaria are ubiquitously distributed on plants. The Alternaria metabolite alternariol and its monomethyl ether are classified as being genotoxic (EFSA 2011). […]
Do you like it?
Read more
Load more

  • Direkter Kontakt
  • zum Team Referenzsubstanzen